This inventor holds 1 USPTO granted patent. Top assignee: Tilt Biotherapeutics Oy. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Keisuke Watanabe: Innovator in Chimeric Antigen Receptor Therapy
Introduction
Keisuke Watanabe is a prominent inventor based in Wynnewood, PA (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of innovative therapies that utilize chimeric antigen receptors.
Latest Patents
Watanabe holds a patent for a groundbreaking invention titled "Combination Therapy Using a Chimeric Antigen Receptor." This patent represents a significant advancement in the treatment of various diseases, showcasing his expertise and dedication to improving patient outcomes. He has 1 patent to his name.
Career Highlights
Watanabe is currently associated with Tilt Biotherapeutics Oy, a company known for its cutting-edge research in the field of immunotherapy. His work at Tilt Biotherapeutics Oy has positioned him as a key player in the development of novel therapeutic strategies.
Collaborations
Throughout his career, Watanabe has collaborated with notable professionals in the field, including Carl H. June and Sonia Guedan Carrio. These collaborations have further enhanced his research and contributed to the advancement of chimeric antigen receptor therapies.
Conclusion
Keisuke Watanabe is a distinguished inventor whose work in chimeric antigen receptor therapy is paving the way for innovative treatments. His contributions to the field are invaluable, and his ongoing research continues to inspire advancements in biotherapeutics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile